Latest Singapore News

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

New Hope Corporation is raising A$300 million through a new convertible notes issue while simultaneously seeking to repurchase its existing A$300 million notes. The move coincides with elevated thermal coal prices amid Middle East tensions and ongoing operational guidance.

Love Group Global Ltd reported a 15% decline in quarterly customer cash receipts to $884k in Q3 FY26, driven by a sharp drop in Hong Kong. Despite this, the company maintained positive net operating cash flow and is pursuing growth in US and UK markets.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Pacific Edge reported a 2.7% increase in test volumes for Q4 2026 despite operational challenges, supported by growing momentum toward Medicare coverage and expanded commercial payer adoption in the US and Asia Pacific.

Elanor Investors Group posted a net loss after tax of $13.8 million for the half year ended 31 December 2025, with no interim distribution declared. The group is progressing a strategic recapitalisation with Rockworth Capital Partners to strengthen its balance sheet amid ongoing financial challenges and material uncertainty about its ability to continue as a going concern.

Xamble Group Limited is set to complete its acquisition of a majority stake in YouthsToday, expanding its influencer marketing platform across Southeast Asia and initiating an AI-driven transformation to enhance profitability and efficiency.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Kelsian Group’s UK arm has clinched a five-year Liverpool bus franchising contract worth $80 million, marking a strategic foothold in the UK’s evolving public transport sector.